Collagen Radiation Tiles Offer New Hope for Patients With Brain Metastases

A multicentre Phase 3 clinical trial led by The University of Texas MD Anderson Cancer Center has reported a major advance for patients with newly diagnosed brain metastases that require surgery: implanting tiny cesium-131 collagen radiation tiles directly into the surgical cavity at the time of tumour removal significantly improved tumour control, reduced recurrence and helped patients live longer compared with the current standard approach of surgery followed by postoperative stereotactic radiation therapy. The treatment, known as tile-based radiation therapy, works by delivering targeted radiation immediately after the brain tumour is removed, rather than waiting days or weeks for the patient to recover before external radiation begins. This matters because brain metastases can regrow quickly, and delays between surgery and radiation may create a dangerous treatment gap. The ROADS trial found that the implanted tiles dramatically lowered surgical-site recurrence and improved both recurrence-free survival and overall survival, with researchers suggesting the approach could become a new standard of care for selected patients whose cancers have spread to the brain. While the results are highly encouraging, the therapy still requires specialist surgical and radiation-oncology expertise, careful patient selection and access to centres equipped to deliver this advanced form of treatment.